EU approves aortic heart valve from Sorin Group

02/3/2011 | CardiovascularBusiness.com

Sorin Group has been granted CE Mark approval for its aortic valve replacement device, the Perceval S, designed for aortic stenosis patients. Surgeons testing the device in a clinical study were able to perform isolated and complex valve replacement procedures in half the time the traditional method takes, the company said.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ